Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.17364 | 68 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.1406 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.14463 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.14444 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.09819 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.17225 | 68 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.14062 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.4209 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.93505 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.13063 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.98943 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.10415 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.12803 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.13092 | 68 |